NEED TO KNOW
A series of acquisitions during the past several years has enabled contract manufacturer Helix Medical LLC (Carpinteria, CA; www.helixmedical.com) to broaden its offerings to the medical device market. Additional manufacturing facilities, along with thermoplastic injection molding services, are expected to complement the company’s current capabilities, which include liquid injection, compression, insert, and two-shot molding, as well as extrusion, assembly, packaging, and sterilization.
The acquisition of Apec (Baldwin Park, CA; www.apecplastics.com) earlier this year has equipped Helix to meet the thermoplastic injection molding needs of the industry. Apec’s operations comprise a 72,000-sq-ft facility in Southern California and a 35,000-sq-ft medical component manufacturing facility in Shenzhen, China. Equipment includes Arburg and Toyo presses ranging from 28 to 300 tn, and seven silicone liquid injection molding cells that enable the company to process both thermoplastics and silicones in the same Class 100,000 cleanroom.
Also a manufacturer of a proprietary brand of platinum-cured silicone tubing, Helix has further bolstered its silicone expertise in recent years through the purchase of a Gloucester, MA–based manufacturer specializing in silicone-based healthcare products. The company, formerly named Jenline Industries Ltd., became a division of Helix Medical in 2007 and was renamed Helix Medical–Gloucester Operations in 2008.
“We are well positioned to meet the needs of our customers with these additional manufacturing operations and continue our hallmark service offerings of extrusion and custom molding of platinum-cured silicone products for the medical device, healthcare, pharmaceutical, and biotech industries,” says Jorg Schneewind, CEO, Helix Medical.